Researchers Successfully Apply CRISPR/Cas9 Gene Editing to Entamoeba histolytica Parasite
Researchers have successfully used CRISPR/Cas9 to knock out and edit a key virulence gene in Entamoeba histolytica, the parasite responsible for amoebiasis, marking the first-ever editing of its endogenous genome. E. histolytica causes significant global morbidity and mortality but has long been difficult to study due to its complex genome and a lack of genetic tools. This breakthrough opens the door to systematic investigation of how the parasite causes disease, potentially accelerating the development of new treatments.
A new study published on bioRxiv reports the first successful CRISPR/Cas9-based editing of the endogenous genome of Entamoeba histolytica, the protozoan parasite that causes amoebiasis, a diarrheal disease responsible for substantial illness and death worldwide. The researchers targeted cysteine protease 5 (CP5), a well-characterized virulence factor, achieving both gene knockout and precise editing of the native chromosomal locus. Beyond the CRISPR work itself, the team developed several supporting tools, including a viral skip peptide delivery approach and a panel of endogenous promoters capable of driving tunable levels of gene expression. They also conducted the most comprehensive empirical testing of nuclear localization signals ever performed in this organism. E. histolytica has historically lagged behind other parasites in genetic tractability due to its unusual genome features and the near-total absence of tools for manipulating endogenous genes. Prior CRISPR attempts in this organism had been limited to editing of episomal plasmids rather than chromosomal DNA. Together, these advances substantially expand the genetic toolkit available for E. histolytica research and lay the groundwork for mechanistic studies of its pathogenesis.
What's missing
As a preprint, this work has not yet undergone formal peer review, so findings should be interpreted with appropriate caution. The study does not report functional phenotypic data characterizing the consequences of CP5 knockout on parasite virulence in host infection models, leaving the downstream biological impact of the editing uncharacterized.
What different sources said
- bioRxivCenter
CRISPR/Cas9 knockout and editing of the major cysteine protease in Entamoeba histolytica
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.